Clinical Trial Update: Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and effectiveness of alendronate for bone mineral density in HIV-infected children and adolescents (NIAID-sponsored).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-03-28